Literature DB >> 19220271

PTEN-mediated pathways and their association with treatment-resistant prostate cancer.

Christopher C Uzoh1, Claire M Perks, Amit Bahl, Jeff M P Holly, Marto Sugiono, Raj A Persad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19220271     DOI： 10.1111/j.1464-410X.2009.08411.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  15 in total

Review 1.  Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.

Authors:  Andréia Vasconcelos-Dos-Santos; Rafaela Muniz de Queiroz; Bruno da Costa Rodrigues; Adriane R Todeschini; Wagner B Dias
Journal:  J Bioenerg Biomembr       Date:  2018-01-11       Impact factor: 2.945

Review 2.  Skp2: a novel potential therapeutic target for prostate cancer.

Authors:  Zhiwei Wang; Daming Gao; Hidefumi Fukushima; Hiroyuki Inuzuka; Pengda Liu; Lixin Wan; Fazlul H Sarkar; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2011-09-22

3.  PTEN-Associated Complexes: An Overview.

Authors:  Sherly Mosessian; Hong Wu
Journal:  Curr Top Biochem Res       Date:  2010

4.  Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel.

Authors:  C C Uzoh; J M P Holly; K M Biernacka; R A Persad; A Bahl; D Gillatt; C M Perks
Journal:  Br J Cancer       Date:  2011-04-12       Impact factor: 7.640

5.  Potential and challenges of specifically isolating extracellular vesicles from heterogeneous populations.

Authors:  Susann Allelein; Paula Medina-Perez; Ana Leonor Heitor Lopes; Sabrina Rau; Gerd Hause; Andreas Kölsch; Dirk Kuhlmeier
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

6.  PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha.

Authors:  Chunhua Yang; Shujing Li; Miao Wang; Alan K Chang; Ying Liu; Feng Zhao; Liyun Xiao; Lin Han; Dao Wang; Shen Li; Huijian Wu
Journal:  Mol Cancer       Date:  2013-03-21       Impact factor: 27.401

7.  MicroRNA 100: a context dependent miRNA in prostate cancer.

Authors:  Katia R M Leite; Denis R Morais; Sabrina T Reis; Nayara Viana; Caio Moura; Manuel Garcia Florez; Iran A Silva; Nelson Dip; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

8.  Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.

Authors:  Kathleen Gabriel; Alistair Ingram; Richard Austin; Anil Kapoor; Damu Tang; Fadwa Majeed; Talha Qureshi; Khalid Al-Nedawi
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

Review 9.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 10.  PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.

Authors:  Nahal Haddadi; Yiguang Lin; Glena Travis; Ann M Simpson; Najah T Nassif; Eileen M McGowan
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.